Michigan Cannabis Grower Loses $32M Judgment in Federal Appeals Court
A federal appellate panel upheld a $32 million judgment against a Michigan marijuana cultivator, marking one of the state's largest cannabis-related commercial losses.

Close-up image of a wooden gavel held by hand on a desk in a courtroom setting.
Federal Panel Upholds Full Judgment
The federal appeals court affirmed the $32 million judgment without modification, rejecting the grower's arguments for reversal or reduction. The decision closes the appellate phase for the Michigan-based cannabis operator, which now faces enforcement of the full award.
The judgment represents one of the largest adverse rulings against a licensed cannabis business in Michigan since adult-use sales launched in December 2019.
Liability Exposure for Michigan Operators
The $32 million figure underscores the scale of commercial risk facing mid-sized and large cannabis cultivators operating under state licenses. Michigan's top-tier cultivation facilities typically generate $15 million to $40 million in annual revenue. That means this judgment could exceed one year's gross sales for many operators.
The ruling arrives as Michigan wholesale flower prices have declined 22% year-over-year through Q3 2026, compressing margins for growers already managing elevated operating costs and 280E tax burdens.
Implications for Cannabis Contract Disputes
Federal court jurisdiction in this case signals the dispute likely involved interstate commerce elements or federal question claims, not purely state cannabis licensing matters. Key takeaways for operators:
- Cannabis businesses remain subject to federal court jurisdiction for contract, tort, and commercial claims despite Schedule I status
- State-licensed activity doesn't shield operators from federal civil liability
- Judgments of this magnitude can trigger involuntary bankruptcy or receivership proceedings
Michigan Market Context
Michigan's cannabis market generated $3.2 billion in sales in 2025, making it the third-largest adult-use market in the U.S. The state's 1,400+ licensed businesses operate in a fiercely competitive environment with thin margins and frequent commercial litigation.
For full background on Michigan's cannabis regulatory structure, see the CannIntel topic hub on Michigan Cannabis Industry.
What the Grower Faces Next
With appellate options exhausted at this level, the cultivator's remaining paths include petition for en banc rehearing, Supreme Court review, or settlement negotiations. Neither option is likely to delay judgment enforcement significantly. The plaintiff can now pursue collection through asset seizure, liens on cultivation facilities, or claims against business accounts—Michigan law permits garnishment of business receivables, including dispensary purchase orders.
Precedent for Cannabis Commercial Litigation
The decision adds to a growing body of federal case law treating state-licensed cannabis operators as commercial parties subject to ordinary contract and tort enforcement. Federal courts have increasingly accepted jurisdiction over cannabis business disputes when the underlying claims don't require the court to affirmatively aid cannabis distribution.
This approach contrasts with earlier judicial reluctance to hear cannabis cases. It reflects evolving federal tolerance for ancillary civil enforcement even as criminal prohibition persists.
Market and Investor Impact
Judgments of this size can force asset sales, trigger change-of-control provisions in operating agreements, or push operators into state receivership under Michigan's Cannabis Regulatory Agency oversight. Investors in private cannabis debt or equity should monitor:
- Disclosure of material litigation in operating agreements and investor updates
- Insurance coverage gaps—most cannabis liability policies cap at $5M to $10M per occurrence
- Subordination risk if judgment creditors gain senior claims on cultivation assets
The next signal: whether the grower pursues en banc review or moves to settle. Either path will clarify the timeline for asset liquidation or operational restructuring.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Local Cannabis Company Secures $15M Financing Round
A Massachusetts-based cannabis operator closed over $15 million in debt financing on September 12, 2026.

New Report Quantifies U.S. Hemp-Cannabinoid Sector Value
Industry analysis highlights economic footprint of hemp-derived cannabinoid market amid ongoing regulatory uncertainty.

Illinois Adult-Use Retailers Claim 75% of New Medical Permits
State's latest medical dispensary lottery shows established recreational operators dominating the draw, raising equity concerns.
More from the newsroom

Missouri Finalizes Hemp THC Restrictions Despite Federal Delay
State regulators advance intoxicating hemp rules while DEA postpones nationwide ban to 2027.

Alliance Group Loses Drug Test Dismissal Case Over Medical Cannabis
New Zealand's Employment Relations Authority ruled against the meat processor in a wrongful termination dispute involving a worker's medicinal cannabis use.

Mexico Supreme Court Allows Cannabis-Infused Foods for Personal Use
SCJN ruling extends constitutional protections to edibles, marking significant expansion of personal-consumption rights.